A recent study highlights how DNA microarray technology enables high-throughput gene analysis, supporting variation detection, expression profiling, and clinical research. By refining probe design and ...

By Dr. Priyom Bose, Ph.D. By transforming standard H&E slides into virtual multiplex protein maps, GigaTIME reveals how ...

The biochips market is poised for robust growth driven by technological advancements and increased healthcare needs. Opportunities abound in diagnostics, drug discovery, and personalized medicine, ...

North America remains the largest contributor to the global exosomes market, driven by substantial R&D investments, expanding clinical trials, and strong collaborations between biotechnology companies ...

The global Proteomics Market is on a rapid growth trajectory, projected to reach USD 134.82 billion by 2035 from an estimated USD 44.79 billion in 2025, reflecting a robust CAGR of 11.7%. Driven by ...

A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an ...

Pancreatic cancer is one of the deadliest malignancies, with survival rates remaining dismally low despite major advances in ...

A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort ...

Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...

This valuable study presents an analysis of the gene regulatory networks that contribute to tumour heterogeneity and tumor plasticity in Ewing sarcoma, with key implications for other fusion-driven ...

Breast cancer remains the most frequently diagnosed cancer among women worldwide, with significant disparities in incidence, molecular subtypes, treatment ...